To assess the toxicity, efficacy, and applicability of high-dose therapy with bone marrow and/or peripheral-blood autotransplantation in high-risk, previously untreated patients with multiple myeloma.
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma / A. M. Gianni, C. Tarella, M. Bregni, S. Siena, F. Lombardi, L. Gandola, D. Caracciolo, A. Stern, G. Bonadonna, M. Boccadoro. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 12:3(1994 Mar), pp. 503-9-509.
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma
A. M. Gianni;C. Tarella;S. Siena;
1994
Abstract
To assess the toxicity, efficacy, and applicability of high-dose therapy with bone marrow and/or peripheral-blood autotransplantation in high-risk, previously untreated patients with multiple myeloma.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
